Chitosan is a cationic polymer derived by deacetylation of chitin obtained from crustaceans. Chitosan is the second most polymers used in industries after cellulose (
1). Biodegradable and mucoadhesion properties of chitosan have recently led to increasing the interest in the development of slow-release formulations for gastro-retentive drug delivery (
2). Chitosan-based dosage forms of this kind could be useful in relation,
e.g., to the administration of antibiotics used for eradication of
Helicobacter pylori in stomach. The present trend, in industrial applications, however, is toward producing high value products, such as cosmetics, drug carriers, feed additives, semi-permeable membranes, and pharmaceutics. The difference in value between the products and the low-cost polymer is one of the main driving forces pushing studies on new applications of chitosan (
1). Biotechnology is currently attempting large-scale production of high-value bio-products like monoclonal antibodies, Immobilization techniques,
etc. Previously, it was investigated that in
Aspergillus niger cell wall constituents, chitin comprises of 42% and also researchers confirmed that the chitosan content of fungi depends on fungal strains, mycelial age, cultivation medium and conditions (
3). The chitosan quantity also depends on the extraction methods (
3).
Rhizopus oryzae TISTR3189 was found to produce maximum yield of chitosan 138 mg/L dry weight,
i.e. (14%) (
4). Nowadays, scientists are paying their attention to find out a new source of organisms which is freely available and easy to cultivate in production of chitosan for the industrial purpose. This study, aimed the utilization of newer fungal strains, by varying the growth medium and incubation periods to get the maximum yield of biomass and excess production of chitosan.